STOCK TITAN

Healwell AI A SUB VTG (HWAIF) Stock News

HWAIF OTC

HEALWELL AI Inc. develops and commercializes healthcare artificial intelligence software for preventative care, with a focus on clinical decision support, early disease identification, and workflow tools for healthcare providers. News about HWAIF commonly covers the company’s DARWEN™ AI platform, Smart Search, Smart Summary, Smart ID, and the use of AI-enriched clinical data to support real-world evidence across disease areas.

Company updates also include revenue and Adjusted EBITDA reporting, integration of Orion Health, enterprise health-system and Health Information Exchange software contracts, customer renewals, scientific publications, conference participation, and board or governance changes. HEALWELL trades on the Toronto Stock Exchange as AIDX and on the OTCQX market as HWAIF.

Rhea-AI Summary

HEALWELL AI (HWAIF) reported third-quarter 2026 revenue from continuing operations of C$32.6 million, up 7% year over year. Adjusted EBITDA, a non-standardized profitability measure, rose 144% to C$1.6 million. The continuing-operations net loss remained approximately C$16.0 million, while gross margin fell to 52% from 54%.

Nine-month operating cash flow turned positive at C$5.9 million, versus C$20.1 million used a year earlier. September-end cash was C$14.9 million, down from C$18.6 million at December-end. Healthcare Software revenue grew 9% in the quarter; Data Science & AI revenue fell to C$1.5 million from C$2.0 million. Orion Health signed a multi-million-dollar, multi-year agreement with Converge Health Iowa, expected to generate recurring revenue. HEALWELL's indirect SpaceX interest was valued at C$17.7 million, with lock-up restrictions expected to fully expire in February 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.57%
Tags
none
-
Rhea-AI Summary

HEALWELL AI (HWAIF) will hold a conference call and simultaneous webcast to discuss third-quarter results on November 10, 2026. The call begins at 8:30 a.m. EST. Results for the fiscal third quarter ended September 30, 2026, will be released after market close on November 9, 2026. CEO James Lee, President Dr. Alexander Dobranowski and CFO Anthony Lam will host the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
conferences earnings AI
-
Rhea-AI Summary

HEALWELL AI (HWAIF) announced that the Competition Bureau concluded its review of WELL Health Technologies’ acquisition of a majority interest in HEALWELL. The Commissioner of Competition issued a No Action Letter on October 22, 2026. It confirms that the Commissioner does not, at this time, intend to apply under section 92 of the Competition Act regarding the transaction.

WELL’s acquisition of a controlling interest in HEALWELL was completed on April 1, 2025, alongside HEALWELL’s acquisition of Orion Health. Both acquisitions were included in the transaction reviewed. In December 2025, the Bureau announced that it had obtained a Federal Court order requiring records and information relating to the transaction. HEALWELL and WELL cooperated throughout the review and supplied the requested materials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags
Rhea-AI Summary

HEALWELL AI (HWAIF) was named to TIME's 2026 healthtech ranking and announced a fall program of 12 scientific presentations. The company was recognized in the AI & Data Analytics category of the 500-company ranking, developed with Statista.

The program spans 8 international conferences, with 9 presentations still to come through November. It includes 8 ethics-approved real-world evidence studies with 7 life sciences partners across 5 therapeutic areas, plus 4 HEALWELL-led presentations on clinical AI. Real-world evidence research draws on clinical records using the DARWEN platform.

Including these presentations, HEALWELL and Pentavere research has had 20 abstracts and manuscripts accepted or published in 2026 across 12 scientific congresses and 4 peer-reviewed journals. DARWEN's research base now spans 57+ peer-reviewed publications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.41%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (HWAIF) highlighted peer-reviewed research on VeroSource’s MyHealth patient app and international recognition of its DARWEN AI abstract.

The MyHealthNB study, published in the Journal of Medical Internet Research on April 28, 2026, reported statistically significant, self-reported improvements in patient empowerment and healthcare engagement. At least 65% of respondents felt empowered to take a more active role in their health and health care; respondents also reported reduced unnecessary calls, travel and duplicate interactions.

DARWEN’s abstract was selected as one of 10 additional submissions for the HealthAI Global Governance Forum’s “Beyond the Room” digital programme. The forum takes place in London on November 18, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (HWAIF) will present at the Cantech Investment Conference in Toronto on October 8, 2026. President Dr. Alexander Dobranowski will give an investor presentation at 1:30 PM ET in Track 1 and participate in scheduled one-on-one investor meetings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
AI
Rhea-AI Summary

HEALWELL AI (HWAIF), via subsidiary Intrahealth Canada, has deployed its DARWEN-powered SMART Summary clinical AI tool to more than 400 clinicians across New Brunswick within the Profile electronic medical record platform.

SMART Summary consolidates fragmented patient information into a single AI-generated, structured summary inside the EMR, aiming to reduce chart-review time and cognitive load for front-line providers. In a Canada Health Infoway Vendor Innovation Program evaluation with 50 clinicians in Ontario, British Columbia and New Brunswick, 84% said the tool could save them time and 79% would recommend it to a colleague.

This is the first Canadian deployment of HEALWELL’s broader SMART Suite, which also includes SMART Search and SMART Identify, and represents an initial rollout within Intrahealth’s approximately 20,000‑provider network across Canada, Australia and New Zealand. The company plans further SMART Suite implementations in Canada and international markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (HWAIF) reported new peer-reviewed research showing its DARWEN™ AI platform outperforming published benchmarks for leading general-purpose AI models and delivering real-world patient impact in 2026 studies.

At AMIA 2026, DARWEN™-powered SMARTSuite clinical summaries exceeded OpenAI GPT, DeepSeek and Llama benchmarks with average improvements of 43% in ROUGE-1, 21% in ROUGE-2 and 43% in ROUGE-L. Separate AI-MEDX 2026 validation showed DARWEN™ treatment-plan accuracy of 54.7% versus 37.3% for Meta-Llama-3-70B-Instruct in blinded clinician review. A Canadian Journal of Cardiology study of SMART Patient ID identified over 4,100 undertreated heart failure patients and helped drive a 70% improvement in treatment optimization within six months.

Research using DARWEN™ has been accepted across 12 fall 2026 forums and includes collaborations with AstraZeneca, Bayer, Galderma, UCB, Takeda, Arcutis and Merck.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.80%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (HWAIF) and WELL Health announced that the WELLTRUST™ consented patient network, powered by HEALWELL’s DARWEN™ AI, has surpassed 100,000 patient consents since its launch in February 2026.

WELLTRUST is a WELL-managed database of patients who have expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. Consents are captured organically in-clinic via WELLSTAR’s OceanMD platform, which presents consent during digital check-in and records it as a structured, revocable entry in the patient’s chart. DARWEN’s AI matches trial protocols against this standing, continuously refreshed clinical dataset to generate pre-screened participant lists for life sciences sponsors and CROs.

WELL and HEALWELL plan to expand EMR connectivity across WELL’s approximately 275-clinic network, roll out additional digital consent channels, scale toward about one million consented patients, and pursue international expansion, including U.S. and European market readiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
Rhea-AI Summary

HEALWELL (OTCQX: HWAIF, TSX: AIDX), through subsidiary Orion Health, entered a multi-million-dollar, multi-year enterprise contract with Converge Health Iowa, the statewide Health Information Exchange. HEALWELL will deploy DARWEN-powered SMART Search and SMART Summary across an HIE infrastructure that currently receives data from 115 hospitals.

The agreement is expected to generate recurring revenue that HEALWELL describes as substantial relative to the current run rate of its AI & Data Sciences unit, and serves as a cross-sell proof point into Orion Health’s global customer base of approximately 70+ potential HIE opportunities. SMART tools are designed to reduce clinician chart-review burden by rapidly surfacing relevant information from longitudinal records with document-level traceability. A February 2026 Canada Health Infoway demonstration with 50 clinicians reported high perceived time savings, usability and accuracy for SMART Summary.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
AI

FAQ

What is the current stock price of Healwell AI A SUB VTG (HWAIF)?

Healwell AI A SUB VTG (HWAIF) last closed at $0.3924.

What is the market cap of Healwell AI A SUB VTG (HWAIF)?

The market cap of Healwell AI A SUB VTG (HWAIF) is approximately $131.2M.